Serum Folic Acid Status, Genotyping MTHFR 677C-->T, Plasma Homocysteine, DNA Methylation of IGF2 Gene and Microbiota of the Children: Mother-Children Cohort Study

December 29, 2019 updated by: Lestari Octavia, Indonesia University

Serum Folic Acid Status, Genotyping MTHFR 677C-->T of the Mother and Serum Folic Acid Status, DNA Methylation of IGF2 Gene of the Children: East Jakarta Cohort Study

This study is part of the East Jakarta Cohort Study to assess the current micronutrient status of the mothers and their children. The study also includes the assessment of genotyping of MTHFR 677C-->T of the mother and DNA methylation of IGF2 gene of the children.

Study Overview

Status

Completed

Detailed Description

The initial study recruited 315 mothers in the public health centre and one district hospital in East Jakarta. The follow-up study is able to re-visit the 127 of them. This also includes 127 peers of the subject that lives in the same neighbourhood. The design of the study is case-cohort design, part study of the existing cohort. The assessment of the follow-up study includes the mother and the children born in the initial study. Anthropometric measurement, socioeconomic data from a structured questionnaire, biomarker assessment, blood pressure were obtained from the subjects.

Study Type

Observational

Enrollment (Actual)

254

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • DKI Jakarta
      • Jakarta, DKI Jakarta, Indonesia, 10430
        • Universitas Indonesia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 40 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

In 2014, the pregnant mothers in 10 public health centre and one sub-district hospital in East Jakarta were recruited in the study. They were in the third trimester gestation period, receive iron-folic acid supplementation and ANC. In 2018, the repeated collection was conducted to collect follow-up data. We also include peer of the subjects that lived in the same neighbourhood since the first cohort study and have children in the same age with cohort participant

Description

Inclusion Criteria:

  • participant in the previous study
  • apparently healthy
  • data complete
  • voluntarily to participate

Exclusion Criteria:

  • not complete data
  • migrate
  • refuse to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
East Jakarta Cohort Study
One group included in the study was originated from mothers who participated in the first data collection pregnancy. The follow-up study included mothers and their children born as the subject in the follow-up in the study. This study also includes peer of the subjects that lived in the same neighbourhood since the first cohort study and have children in the same age with cohort participant

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum folic acid status
Time Frame: December 2018 - March 2019
The measurement of serum folic acid status is using LC-MS/MS
December 2018 - March 2019
Genotyping MTHFR 677C-->T
Time Frame: December 2018 - March 2019
The assessment of MTHFR 677C-->T using Real Time PCR
December 2018 - March 2019
DNA methylation of IGF2 gene
Time Frame: December 2018 - March 2019
DNA methylation of IGF2 gene using pyrosequencing method
December 2018 - March 2019

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum Homocysteine
Time Frame: December 2018-March 2019
The measurement of serum homocysteine using Electrochemiluminescen
December 2018-March 2019
Serum Adiponectin
Time Frame: December 2018-March 2019
The measurement of serum adiponection using electrochemiluminescence
December 2018-March 2019
Blood pressure
Time Frame: December 2018-March 2019
The blood pressure measurement using semi automatic device (Omron HBP1300)
December 2018-March 2019

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutritional status assessment
Time Frame: September 2018-December 2018
Using antrhopometric measurement, using SECA for weight measurement, Shorrboard for height and standardized plastic tape for mid upper arm circumference.
September 2018-December 2018

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Rina RA Agustina, Doctoral, Indonesia University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 2, 2018

Primary Completion (Actual)

November 20, 2018

Study Completion (Actual)

March 16, 2019

Study Registration Dates

First Submitted

September 18, 2019

First Submitted That Met QC Criteria

September 19, 2019

First Posted (Actual)

September 20, 2019

Study Record Updates

Last Update Posted (Actual)

January 2, 2020

Last Update Submitted That Met QC Criteria

December 29, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

I will not share the IPD of the subject participated due to consent issue

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Folic Acid Deficiency

Subscribe